References
- Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69(14):1811-20. https://doi.org/10.1016/j.jacc.2017.01.052 PMid:28385310
- Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293-300. https://doi.org/10.1016/j.jacc.2006.07.059 PMid:17161262
- Chen ZW, Tsai CH, Pan CT, Chou CH, Liao CW, Hung CS, et al. Endothelial dysfunction in primary aldosteronism. Int J Mol Sci. 2019;20(20):5214. https://doi.org/10.3390/ijms20205214 PMid:31640178
- Ambrosino P, Lupoli R, Tortora A Cacciapuoti M, Lupoli GA, Tarantino P, et al. Cardiovascular risk markers in patients with primary aldosteronism: A systematic review and meta-analysis of literature studies. Int J Cardiol. 2016;208:46-55. https://doi.org/10.1016/j.ijcard.2016.01.200 PMid:26826789
- Lin YH, Lin LY, Chen A, Wu XM, Lee JK, Su TC, et al. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. Atherosclerosis. 2012;221(1):154-9. https://doi.org/10.1016/j.atherosclerosis.2011.12.003 PMid:22197109
- Holaj R, Zelinka T, Wichterle D, Petrák O, Strauch B, Widimský J Jr. Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension. J Hypertens. 2007;25:1451-7. https://doi.org/10.1097/HJH.0b013e3281268532 PMid:17563568
- Bernini G, Galetta F, Franzoni F, Bardini M, Taurino C, Bernardini M, et al. Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens. 2008;26(12):2399-405. https://doi.org/10.1097/HJH.0b013e32831286fd PMid:19008719
- Rossi GP, Sacchetto A, Visentin P, Canali C, Graniero GR, Palatini P, et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension. 1996;27(5):1039-45. https://doi.org/10.1161/01.hyp.27.5.1039 PMid:8621194
- Shigematsu Y, Hamada M, Okayama H, Hara Y, Hayashi Y, Kodama K, et al. Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension. 1997;29(3):723-7. https://doi.org/10.1161/01.hyp.29.3.723 PMid:9052887
- Matsumura K, Fujii K, Oniki H, Oka M, Iida M. Role of aldosterone in left ventricular hypertrophy in hypertension. Am J Hypertens. 2006;19(1):13-8. https://doi.org/10.1016/j.amjhyper.2005.05.013 PMid:16461184
- Reincke M, Fischer E, Gerum S, Merkle K, Schulz S, Pallauf A, et al. Observational study mortality in treated primary aldosteronism: The German Conn’s registry. Hypertension. 2012;60(3):618-24. https://doi.org/10.1161/HYPERTENSIONAHA.112.197111 PMid:22824982
- Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45(8):1243-8. https://doi.org/10.1016/j.jacc.2005.01.015 PMid:15837256
- Stowasser M, Sharman J, Leano R, Gordon RD, Ward G, Cowley D, et al. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism Type I. J Clin Endocrinol Metab. 2005;90(9):5070-6. https://doi.org/10.1210/jc.2005-0681 PMid:15941863
- Grasman R. Meta-Analysis in JASP. Web Publication/Site, JASP; 2017. Available from: https://jaspstats.org/2017/11/15/meta-analysis-jasp [Last accessed on 2023 Jan 12].
- Wu X, Yu J, Tian H. Cardiovascular risk in primary aldosteronism. A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(26):e15985. https://doi.org/10.1097/MD.0000000000015985 PMid:31261504
- Benitah JP, Perrier E, Gomez AM, Vassort G. Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes. J Physiol. 2001;537(Pt 1):151-60. https://doi.org/10.1111/j.1469-7793.2001.0151k.x PMid:11711569
- Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M, et al. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res. 1997;20(2):85-90. https://doi.org/10.1291/hypres.20.85 PMid:9220271
- Chang YY, Liao CW, Tsai CH, Chen CW, Pan CT, Chen ZW, et al. Left ventricular dysfunction in patients with primary aldosteronism: A propensity score-matching follow-up study with tissue Doppler imaging. J Am Heart Assoc. 2019;8(22):e013263. https://doi.org/10.1161/JAHA.119.013263 PMid:31718437
- Cesari M, Letizia C, Angeli P, Sciomer S, Rosi S, Rossi GP. Cardiac remodeling in patients with primary and secondary aldosteronism: A tissue doppler study. Circ Cardiovasc Imaging. 2016;9(6):e004815. https://doi.org/10.1161/CIRCIMAGING.116.004815 PMid:27307552
- Widimsky J Jr., Strauch B, Petrák O, Rosa J, Somloova Z, Zelinka T. Vascular disturbances in primary aldosteronism: Clinical evidence. Kidney Blood Press Res. 2012;35(6):529-33. https://doi.org/10.1159/000340031 PMid:22890049
- Rosa J, Somlóová Z, Petrák O, Strauch B, Indra T, Senitko M. Peripheral arterial stiffness in primary aldosteronism. Physiol Res. 2012;61(5):461-8. https://doi.org/10.33549/physiolres.932344 PMid:2288123
- Lee MY, Lai WT. Plasma renin level and aldosterone to renin ratio are associated with presence of carotid plaques in patients with stable coronary artery disease. J Renin Angiotensin Aldosterone Syst. 2015;16(4):1159-67. https://doi.org/10.1177/1470320314548743 PMid:25237165